VIDEOS AND RECORDINGS

    Explore our videos of past webinar and congress recordings.

Prescribing information for DOVATO (dolutegravir/lamivudine) can be found here.
Prescribing information for VOCABRIA (cabotegravir) + REKAMBYS (rilpivirine) can be found here.

Results:

Showing results for

Dr. Sebastian Noe talks about identifying suitable patients
VOCABRIA + REKAMBYS

UK National Webinar

Dr. Sebastian Noe talks about identifying suitable patients

Prof. Carlo Federico Perno and Dr. Romina Quercia discuss the barrier to resistance
DOVATO

Expert Discussion

Prof. Carlo Federico Perno and Dr. Romina Quercia discuss the barrier to resistance

*The following videos are recordings of a recent national webinar. As the videos are a recording some functionality such as 'Ask a Question', 'click here', AE hyperlink in the video will not work. Prescribing Information is available above.

PM-GB-HVX-WCNT-220003 | November 2024

Adverse event reporting

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK via the GSK Reporting Tool or on 0800 221441.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.